ScholarIQanswers from OpenAlex & ORCID
Frederik Husum Mårup
ResearcherPublications, citations & collaboration network
Frederik Husum Mårup is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Frederik Husum Mårup have?
ScholarIQindexed works
Frederik Husum Mårup has 10 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Frederik Husum Mårup have?
ScholarIQcitation count
Frederik Husum Mårup has 270 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Frederik Husum Mårup?
ScholarIQh-index
Frederik Husum Mårup has an h-index of 4 in OpenAlex.
What is the i10-index of Frederik Husum Mårup?
ScholarIQi10-index
Frederik Husum Mårup has an i10-index of 3 in OpenAlex.
What is the ORCID of Frederik Husum Mårup?
ScholarIQorcid
The ORCID for Frederik Husum Mårup is on the source record.
What is the OpenAlex record for Frederik Husum Mårup?
ScholarIQopenalex
The OpenAlex for Frederik Husum Mårup is on the source record.
What are the most-cited papers on Frederik Husum Mårup?
ScholarIQmost cited works
Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer’s disease
Peter Parbo, Rola Ismail, Kim Vang Hansen, Ali Amidi, Frederik Husum Mårup, Hanne Gottrup, Hans Brændgaard, Bengt O. Eriksson, Simon Fristed Eskildsen, Torben E. Lund, Anna Tietze, Paul Edison, Nicola Pavese, Morten Gersel Stokholm, Per Borghammer, Rainer Hinz, Joel Aanerud, David J. Brooks
Additive effects of dapagliflozin and finerenone on albuminuria in non-diabetic CKD: an open-label randomized clinical trial
Frederik Husum Mårup, Martin Bjergskov Thomsen, Henrik Birn
Can patiromer allow for intensified renin–angiotensin–aldosterone system blockade with losartan and spironolactone leading to decreased albuminuria in patients with chronic kidney disease, albuminuria and hyperkalaemia? An open-label randomised controlled trial: MorphCKD
Frederik Husum Mårup, Christian D. Peters, Jeppe Hagstrup Christensen, Henrik Birn
<scp>SGLT2</scp> inhibition improves endothelium‐independent vasodilatory function in type 2 diabetes: A double‐blind, randomized, placebo‐controlled crossover trial
Didde Kidmose Kristensen, Frank Holden Mose, Niels Henrik Buus, Camilla Lundgreen Duus, Frederik Husum Mårup, Jesper Nørgaard Bech, Steffen Flindt Nielsen
#3068 POTASSIUM LEVELS AND EGFR DO NOT PREDICT SEVERE HYPERKALEMIA FOLLOWING SPIRONOLACTONE INTRODUCTION IN PATIENTS WITH CKD AT HIGH RISK OF HYPERKALEMIA
Frederik Husum Mårup, Christian D. Peters, Steffen Nielsen, Bo Madsen, Louis Nygaard, Frank Holden Mose, Henrik Birn